Jeuveau, also known as prabotulinumtoxin A, is a neurotoxin specifically formulated for cosmetic use medicine that is injected into muscles used to improve the look of moderate to severe fine lines and wrinkles. It targets glabellar lines, frown lines, crow's feet, and lip lines in people aged 18 to 65, temporarily restoring volume and smoothing the skin to enhance facial aesthetics and achieve a natural-looking and youthful appearance.
As an FDA-approved product, Jeuveau is backed by research and clinical studies that demonstrate its safety and effectiveness. The average client with moderate wrinkles might expect to invest 20–40 units, depending on the desired effect.